X4 Pharmaceuticals Inc (FRA:48Q)
€ 0.926 -0.033 (-3.44%) Market Cap: 155.77 Mil Enterprise Value: 135.02 Mil PE Ratio: 0 PB Ratio: 168.33 GF Score: 35/100

Q1 2020 X4 Pharmaceuticals Inc Earnings Call Transcript

May 07, 2020 / 12:30PM GMT
Release Date Price: €8.1 (-2.41%)
Operator

Greetings and welcome to the X4 Pharmaceuticals First Quarter Financial and Operating Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Candice Ellis, Director of Corporate Communications and Investor Relations at X4. You may begin.

Candice Ellis
X4 Pharmaceuticals, Inc. - Director of Corporate Communications and IR

Thank you, operator, and good morning everyone. Thanks so much for joining us as we provide a recap of our first quarter and recent activities to present our financial results and discuss the impact of the COVID-19 pandemic on our business.

Presenting on today's call will be our Chief Executive Officer, Dr. Paula Ragan, and our Chief Financial Officer, Adam Mustafa. Following prepared remarks by each, we will open the call to your questions and they will be joined by our Senior Vice President of Research and Development, Renato Skerlj; and our Senior Vice President of Technical Operations and Quality, Mary DiBiase.

As a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot